SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
Morning Overview on MSN
The FDA cleared the first over-the-counter glucose monitor made for children
Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The ...
San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing just under ...
The FDA’s indication expansion for Dexcom’s Stelo makes it the first over the counter CGM available for children, including those with diabetes.
Oura Ring uses Stelo by Dexcom to show glucose patterns, meal responses, and Time Above Range for users tracking blood sugar awareness ...
Analysis of over 5,000 hours of clinical wear data validates Trinity Biotech’s CGM+ 's purpose-built capability to distinguish nocturnal ...
Stelo is meant for those with Type 2 diabetes as well as people who want more insight into their blood sugar levels. Here's how biosensors are growing in 2024. Jessica was a writer on the Wellness ...
An over-the-counter continuous glucose monitoring (CGM) solution developed by Dexcom called Stelo has received clearance from the Food and Drug Administration (FDA). Available without the need for a ...
You don't need to wait for Apple to add glucose sensing to a smartwatch. Biosensors give you real-time data, and you no longer require a prescription. Jessica was a writer on the Wellness team, with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results